Active not recruiting

A Safety Study of LY3462817 in Participants With Psoriasis

J1A-MC-KDAC - ClinicalTrials.gov - NCT04152382

This study is being conducted to determine how safe and how well tolerated LY3462817 is when given to participants with psoriasis. Blood tests will be done to check how much LY3462817 is in the bloodstream and how long the body takes to get rid of it.
How long will I be in the trial?
The study will last up to one year and one month for each participant.
Email
Active not recruiting

A Safety Study of LY3462817 in Participants With Psoriasis

J1A-MC-KDAC - ClinicalTrials.gov - NCT04152382

This study is being conducted to determine how safe and how well tolerated LY3462817 is when given to participants with psoriasis. Blood tests will be done to check how much LY3462817 is in the bloodstream and how long the body takes to get rid of it.
How long will I be in the trial?
The study will last up to one year and one month for each participant.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have been diagnosed with psoriasis for at least 6 months

Participants must have active psoriasis plaques

Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)

Participants must NOT

Participants must not have received certain medications for psoriasis that are applied to the skin within 14 days prior to baseline (Day 1)

Participants must not have received certain oral or injectable medications or light therapy for psoriasis within 4 weeks prior to baseline

Trial Summary

Conditions the trial is for

Psoriasis

What the trial is testing?

LY3462817 - IV, LY3462817 - SC, Placebo - IV, Placebo - SC

Could I receive a Placebo?

no

Enrollment Goal

64

Trial Dates

November 2019 - October 2021

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must have been diagnosed with psoriasis for at least 6 months

Participants must have active psoriasis plaques

Participants must be willing and able to have skin biopsies (small samples of skin removed for testing)

Participants must NOT

Participants must not have received certain medications for psoriasis that are applied to the skin within 14 days prior to baseline (Day 1)

Participants must not have received certain oral or injectable medications or light therapy for psoriasis within 4 weeks prior to baseline

Trial Summary

Conditions the trial is for

Psoriasis

What the trial is testing?

LY3462817 - IV, LY3462817 - SC, Placebo - IV, Placebo - SC

Could I receive a Placebo?

no

Enrollment Goal

64

Trial Dates

November 2019 - October 2021

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Psoriasis Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?